Future Challenges for Drug Development in Renal Cell Carcinoma
- PMID: 27992269
- DOI: 10.1200/JCO.2016.71.0673
Future Challenges for Drug Development in Renal Cell Carcinoma
Comment in
-
Reply to B. Rini et al and S. Buti et al.J Clin Oncol. 2017 Jun 1;35(16):1859-1860. doi: 10.1200/JCO.2017.72.2629. Epub 2017 Mar 6. J Clin Oncol. 2017. PMID: 28549224 No abstract available.
Comment on
-
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.J Clin Oncol. 2017 Feb 20;35(6):591-597. doi: 10.1200/JCO.2016.70.7398. Epub 2016 Nov 14. J Clin Oncol. 2017. PMID: 28199818 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
